Black Rock Inc. Tarsus Pharmaceuticals, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,266,714 shares of TARS stock, worth $158 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,266,714
Previous 2,652,680
23.15%
Holding current value
$158 Million
Previous $96.4 Million
7.92%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TARS
# of Institutions
170Shares Held
43.3MCall Options Held
484KPut Options Held
4.1K-
Rtw Investments, LP New York, NY3.41MShares$165 Million1.79% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$118 Million2.89% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$109 Million6.32% of portfolio
-
Morgan Stanley New York, NY2.21MShares$107 Million0.01% of portfolio
-
Cowen And Company, LLC2.2MShares$106 Million1.86% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.29B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...